Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

Richard Peto, M. C. Pike, P. Armitage et al. · British Journal of Cancer · 1977 · 8.4K citations · Full text

Public Health, Biostatistics, Clinical Medicine +13

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Brian G.M. Durie, Sydney E. Salmon · Cancer · 1975 · 3.1K citations

Medicine, Hematology, Oncology +15

Maximum utilization of the life table method in analyzing survival

Sidney J. Cutler, Fred Ederer · Journal of Chronic Diseases · 1958 · 2.9K citations

Public Health, Biology, Biostatistics +12

Electroimmuno Assay

C.‐B. Laurell · Scandinavian Journal of Clinical and Laboratory Investigation · 1972 · 1.7K citations

Life Sciences, Immunology, Clinical Immunology +16

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

Daniel E. Bergsagel, A Bailey, G. R. Langley et al. · New England Journal of Medicine · 1979 · 379 citations

Medicine, Oncology, Pharmacology +11